• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mitochondrial subversion in cancer.癌症中线粒体的颠覆
Cancer Prev Res (Phila). 2011 May;4(5):638-54. doi: 10.1158/1940-6207.CAPR-10-0326.
2
Human mitochondrial genome flaws and risk of cancer.人类线粒体基因组缺陷与癌症风险。
Mitochondrial DNA. 2014 Oct;25(5):329-34. doi: 10.3109/19401736.2013.796520. Epub 2013 Jun 12.
3
Mitochondrial DNA mutations in human cancer.人类癌症中的线粒体DNA突变。
Oncogene. 2006 Aug 7;25(34):4663-74. doi: 10.1038/sj.onc.1209604.
4
Somatic mitochondrial DNA mutations in human cancers.人类癌症中的体线粒体 DNA 突变。
Adv Clin Chem. 2012;57:99-138. doi: 10.1016/b978-0-12-394384-2.00004-8.
5
A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.一种异质性而非同质性的线粒体DNA突变通过活性氧生成和细胞凋亡的改变促进肿瘤发生。
Hum Mol Genet. 2009 May 1;18(9):1578-89. doi: 10.1093/hmg/ddp069. Epub 2009 Feb 10.
6
Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.第二部分。高一氧化氮适应细胞系BT-20(BT-20-HNO)的线粒体突变状态及其与人类原发性乳腺肿瘤的关系。
Tumour Biol. 2013 Feb;34(1):337-47. doi: 10.1007/s13277-012-0555-4. Epub 2012 Dec 14.
7
Somatic mutations of mitochondrial DNA in aging and cancer progression.衰老和癌症进展中线粒体 DNA 的体细胞突变。
Ageing Res Rev. 2010 Nov;9 Suppl 1:S47-58. doi: 10.1016/j.arr.2010.08.009. Epub 2010 Sep 8.
8
Significance of Mitochondria DNA Mutations in Diseases.线粒体 DNA 突变在疾病中的意义。
Adv Exp Med Biol. 2017;1038:219-230. doi: 10.1007/978-981-10-6674-0_15.
9
Spotlight on the relevance of mtDNA in cancer.聚焦线粒体DNA在癌症中的相关性。
Clin Transl Oncol. 2017 Apr;19(4):409-418. doi: 10.1007/s12094-016-1561-6. Epub 2016 Oct 24.
10
Mitochondrial DNA Mutations are Associated with Ulcerative Colitis Preneoplasia but Tend to be Negatively Selected in Cancer.线粒体 DNA 突变与溃疡性结肠炎癌前病变相关,但在癌症中倾向于被负选择。
Mol Cancer Res. 2019 Feb;17(2):488-498. doi: 10.1158/1541-7786.MCR-18-0520. Epub 2018 Nov 16.

引用本文的文献

1
Atypical R-loops in cancer: decoding molecular chaos for therapeutic gain.癌症中的非典型R环:破解分子混乱以实现治疗效益。
J Transl Med. 2025 Aug 14;23(1):912. doi: 10.1186/s12967-025-06929-x.
2
Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study.线粒体DNA拷贝数变异与三阴性乳腺癌的关联:一项潜在生物标志物研究
Diseases. 2025 Jun 1;13(6):175. doi: 10.3390/diseases13060175.
3
Understanding the impact of mitochondrial DNA mutations on aging and carcinogenesis (Review).了解线粒体DNA突变对衰老和致癌作用的影响(综述)。
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5559. Epub 2025 Jun 6.
4
Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple-negative breast cancer patients for potential biomarker development.分析三阴性乳腺癌患者肿瘤组织及循环细胞外囊泡中的线粒体DNA突变以开发潜在生物标志物。
FASEB Bioadv. 2023 Sep 8;5(10):412-426. doi: 10.1096/fba.2023-00070. eCollection 2023 Oct.
5
Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma.含卷曲螺旋结构域蛋白58(CCDC58)是一种与肝细胞癌线粒体功能相关的新型预后生物标志物。
Am J Transl Res. 2023 Apr 15;15(4):2568-2584. eCollection 2023.
6
The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies.基因突变在特定肿瘤(乳腺癌和妇科恶性肿瘤)线粒体驱动的肿瘤生长中的作用
Life (Basel). 2023 Apr 12;13(4):996. doi: 10.3390/life13040996.
7
Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma.肺腺癌早期诊断的核基因组和线粒体基因组分子指纹图谱。
J Transl Med. 2023 Apr 10;21(1):250. doi: 10.1186/s12967-023-04099-2.
8
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells.线粒体活性对骨肉瘤细胞阿霉素耐药性的作用
Cancers (Basel). 2023 Feb 21;15(5):1370. doi: 10.3390/cancers15051370.
9
Neoantigens: promising targets for cancer therapy.肿瘤新抗原:癌症治疗的有前途的靶点。
Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x.
10
Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese population.线粒体 DNA 单倍群 M7:中国人群结直肠癌患者预后不良的预测因子。
Cancer Sci. 2023 Mar;114(3):1056-1066. doi: 10.1111/cas.15654. Epub 2022 Dec 7.

本文引用的文献

1
Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data.MitoChip 检测到的肿瘤特异性体细胞突变的潜在陷阱:在解读患者数据时需谨慎。
BMC Cancer. 2010 Oct 30;10:597. doi: 10.1186/1471-2407-10-597.
2
Cancer-associated IDH mutations: biomarker and therapeutic opportunities.癌症相关 IDH 突变:生物标志物和治疗机会。
Oncogene. 2010 Dec 9;29(49):6409-17. doi: 10.1038/onc.2010.444. Epub 2010 Oct 25.
3
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection.通过组织微切割获得的乳腺癌细胞中线粒体基因组全长的突变积累。
Breast Cancer Res Treat. 2011 Jul;128(2):327-36. doi: 10.1007/s10549-010-1092-8. Epub 2010 Aug 10.
4
Mitochondrial DNA mutation in normal margins and tumors of recurrent head and neck squamous cell carcinoma patients.复发性头颈部鳞状细胞癌患者正常边缘和肿瘤中的线粒体 DNA 突变。
Cancer Prev Res (Phila). 2010 Sep;3(9):1205-11. doi: 10.1158/1940-6207.CAPR-10-0018. Epub 2010 Jul 26.
5
The approaches for manipulating mitochondrial proteome.调控线粒体蛋白质组的方法。
Environ Mol Mutagen. 2010 Jun;51(5):451-61. doi: 10.1002/em.20570.
6
DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing.采用下一代测序技术检测 DNA 拷贝数,包括端粒和线粒体。
BMC Genomics. 2010 Apr 16;11:244. doi: 10.1186/1471-2164-11-244.
7
Heteroplasmic mitochondrial DNA mutations in normal and tumour cells.正常细胞和肿瘤细胞中的异质体线粒体 DNA 突变。
Nature. 2010 Mar 25;464(7288):610-4. doi: 10.1038/nature08802. Epub 2010 Mar 3.
8
Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study.前瞻性队列研究中线粒体 DNA 拷贝数与肺癌风险。
Carcinogenesis. 2010 May;31(5):847-9. doi: 10.1093/carcin/bgq045. Epub 2010 Feb 22.
9
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.癌症相关的 IDH1 突变会产生 2-羟基戊二酸。
Nature. 2009 Dec 10;462(7274):739-44. doi: 10.1038/nature08617.
10
Following mitochondrial footprints through a long mucosal path to lung cancer.沿着线粒体的足迹,穿过漫长的黏膜途径到达肺癌。
PLoS One. 2009 Aug 6;4(8):e6533. doi: 10.1371/journal.pone.0006533.

癌症中线粒体的颠覆

Mitochondrial subversion in cancer.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Cancer Prev Res (Phila). 2011 May;4(5):638-54. doi: 10.1158/1940-6207.CAPR-10-0326.

DOI:10.1158/1940-6207.CAPR-10-0326
PMID:21543342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3298745/
Abstract

Mitochondria control essential cellular activities including generation of ATP via oxidative phosphorylation. Mitochondrial DNA (mtDNA) mutations in the regulatory D-loop region and somatic mtDNA mutations are common in primary human cancers. The biological impact of a given mutation may vary, depending on the nature of the mutation and the proportion of mutant mtDNAs carried by the cell. Identification of mtDNA mutations in precancerous lesions supports their early contribution to cell transformation and cancer progression. Introduction of mtDNA mutations in transformed cells has been associated with increased ROS production and tumor growth. Studies reveal that increased and altered mtDNA plays a role in the development of cancer but further work is required to establish the functional significance of specific mitochondrial mutations in cancer and disease progression. This review offers some insight into the extent of mtDNA mutations, their functional consequences in tumorigenesis, mitochondrial therapeutics, and future clinical application.

摘要

线粒体控制着包括通过氧化磷酸化产生 ATP 在内的基本细胞活动。调节区 D-环的线粒体 DNA (mtDNA) 突变和体细胞 mtDNA 突变在原发性人类癌症中很常见。给定突变的生物学影响可能因突变的性质和细胞携带的突变 mtDNA 的比例而异。在癌前病变中检测到 mtDNA 突变支持它们对细胞转化和癌症进展的早期贡献。在转化细胞中引入 mtDNA 突变与增加的 ROS 产生和肿瘤生长有关。研究表明,增加和改变的 mtDNA 在癌症的发展中起作用,但需要进一步的工作来确定特定线粒体突变在癌症和疾病进展中的功能意义。这篇综述提供了一些关于 mtDNA 突变的程度、它们在肿瘤发生中的功能后果、线粒体治疗以及未来临床应用的见解。